Barclays’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.28M | Buy |
|
|||||
|
2025
Q2 | $1.13M | Buy |
|
|||||
|
2025
Q1 | $938K | Buy |
|
|||||
|
2024
Q4 | $1.14M | Buy |
|
|||||
|
2024
Q3 | $956K | Buy |
|
|||||
|
2024
Q2 | $535K | Sell |
|
|||||
|
2024
Q1 | $1.02M | Buy |
|
|||||
|
2023
Q4 | $814K | Sell |
|
|||||
|
2023
Q3 | $470K | Buy |
|
|||||
|
2023
Q2 | $394K | Sell |
|
|||||
|
2023
Q1 | $957K | Sell |
|
|||||
|
2022
Q4 | $5.94M | Buy |
|
|||||
|
2022
Q3 | $2.4M | Sell |
|
|||||
|
2022
Q2 | $12.5M | Sell |
|
|||||
|
2022
Q1 | $7.04M | Buy |
|
|||||
|
2021
Q4 | $10M | Buy |
|
|||||
|
2021
Q3 | $3.2M | Buy |
|
|||||
|
2021
Q2 | $670K | Buy |
|
|||||
|
2021
Q1 | $464K | Buy |
|
|||||
|
2020
Q4 | $319K | Buy |
|
|||||
|
2020
Q3 | $372K | Sell |
|
|||||
|
2020
Q2 | $1.28M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $0 | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $10K | Buy |
|
|||||
|
2017
Q1 | $3K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2014
Q3 | – | Hold |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|
|||||
|
2013
Q4 | – | Hold |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $2K | Buy |
|